Brain, Vol. 115, No. 6, 1611-1631, 1992
© 1992 Guarantors of Brain
research-article |
INTERACTIONS BETWEEN OLIGODENDROCYTES AND MICROGLIA
A MAJOR ROLE FOR COMPLEMENT AND TUMOUR NECROSIS FACTOR IN OLIGODENDROCYTE ADHERENCE AND KILLING
1University of Cambridge Neurology unit Cambridge, UK 2Molecular Immunopathology Unit, MRC Centre Addenbrookes Hospital Cambridge, UK
Correspondence to:
Correspondence to: J. P. Zajicek, University of Cambridge Neurology unit, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK.
Interactions between rat microglia and oligodendrocytes were examined in vitro in order to characterize the stages of adherence, phagocytosis and cytotoxicity against oligodendrocytes by microglia. Under resting conditions, microglia showed minimal contact with oligodendrocytes and exhibited surface staining of myelin basic protein and myelin debris only; they were not cytotoxic for oligodendrocytes and did not produce tumour necrosis factor (TNF). On activation with either
-interferon or lipopolysaccharide and interferon, these cells increased surface binding for myelin basic protein, showed greater contact with living oligodendrocytes and produced TNF in both secreted and cell surface bound forms. Secreted TNF was capable of killing oligodendrocytes but the cell surface bound form did this more efficiently. In the presence of complement, activated microglia showed significant phagocytosis of myelin basic protein which was not obvious in the unactivated cells. These results suggest that activated microglia in the presence of complement are sufficient to kill and phagocytose the oligodendrocyte-myelin complex in vitro
Received April 13, 1992. Revised June 8, 1992. Accepted June 16, 1992.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M H Barnett, A P. Henderson, and J W Prineas The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion Multiple Sclerosis, April 1, 2006; 12(2): 121 - 132. [Abstract] [PDF] |
||||
![]() |
A. Jurewicz, M. Matysiak, K. Tybor, L. Kilianek, C. S. Raine, and K. Selmaj Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor Brain, November 1, 2005; 128(11): 2675 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Zajicek Diagnosis and disease modifying treatments in multiple sclerosis Postgrad. Med. J., September 1, 2005; 81(959): 556 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Shields, K. E. Schaecher, T. C. Saido, and N. L. Banik A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain PNAS, September 28, 1999; 96(20): 11486 - 11491. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Dammann and A. Leviton Brain Damage in Preterm Newborns: Might Enhancement of Developmentally Regulated Endogenous Protection Open a Door for Prevention? Pediatrics, September 1, 1999; 104(3): 541 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Sullivan, A. J. Bruce-Keller, A. G. Rabchevsky, S. Christakos, D. K. St. Clair, M. P. Mattson, and S. W. Scheff Exacerbation of Damage and Altered NF-kappa B Activation in Mice Lacking Tumor Necrosis Factor Receptors after Traumatic Brain Injury J. Neurosci., August 1, 1999; 19(15): 6248 - 6256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Akassoglou, J. Bauer, G. Kassiotis, M. Pasparakis, H. Lassmann, G. Kollias, and L. Probert Oligodendrocyte Apoptosis and Primary Demyelination Induced by Local TNF/p55TNF Receptor Signaling in the Central Nervous System of Transgenic Mice : Models for Multiple Sclerosis with Primary Oligodendrogliopathy Am. J. Pathol., September 1, 1998; 153(3): 801 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. D'Souza, B. Bonetti, V. Balasingam, N. R. Cashman, P. A. Barker, A. B. Troutt, C. S. Raine, and J. P. Antel Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death J. Exp. Med., December 1, 1996; 184(6): 2361 - 2370. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Zajicek and A Compston Mechanisms of damage and repair in multiple sclerosis -- a review Multiple Sclerosis, June 1, 1995; 1(2): 61 - 72. [Abstract] [PDF] |
||||







